Imported severe West Nile virus neuro-invasive disease treated by remdesivir in a patient with anti-CD20 therapy for multiple sclerosis: A case report
<h2>Abstract</h2> West Nile virus (WNV) infection can lead to severe disease, especially in immunocompromised individuals. We report a case of neuroinvasive WNV in a patient receiving ocrelizumab for multiple sclerosis, who recovered after remdesivir and immunoglobulin treatment. This case highlights the diagnostic and therapeutic challenges regarding neuroinvasive WNV infection in immunocompromised patients.
Authors
- Florian Laubscher (ORCID: https://orcid.org/0000-0002-8803-981X)
- Matteo Coen (ORCID: https://orcid.org/0000-0002-6156-1691)
- Marjolaine Uginet (ORCID: https://orcid.org/0000-0001-5997-7500)
- Ehtesham Shamsher (ORCID: https://orcid.org/0000-0003-4854-7024)
- Pauline Vetter (ORCID: https://orcid.org/0000-0002-9902-5069)
- Jonathan Dash
- Manuel Schibler
- Jacques Serratrice (ORCID: https://orcid.org/0000-0002-1329-4963)
- Aurélie Zacharias-Fontanet
Institutions
- John Radcliffe Hospital (GB)
- University Hospital of Geneva (CH)
- Geneva College (US)
Publication Details
- Journal
- CMI Communications
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.cmicom.2024.105034
- Citations
- 4
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 2.17